Skip to main content
SpringerLink
Log in

Oxcarbazepine

  • Chapter
Antiepileptic Drugs

Part of the book series: Handbook of Experimental Pharmacology ((HEP,volume 138))

  • 492 Accesses

Abstract

Oxcarbazepine (OXC) was first introduced in 1990, in Denmark, and is now registered in 31 countries worldwide for use as monotherapy and as add-on treatment for partial seizures, whether or not they became secondarily generalized, and for primary generalized tonic-clonic seizures. The estimated patient exposure to the drug currently exceeds 50,000 patient years. Oxcarbazepine is under active investigation in the United States.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Augusteijn R, van Parys JAP (1990) Oxcarbazepine (Tripetal, OXC) — doseconcentration relationship in patients with epilepsy. Acta Neurol Scand 82 [Suppl 133]:37

    Google Scholar 

  • Bill PA, Vigonius U, Pohlmann H, Guerrio CAM, Kochen S, Saffer D, Moore A (1997) A double-blind controlled clinical trial of oxcarbazepine versus phenytoin in adults with previously untreated epilepsy. Epilepsy Res 27:195–204

    Article  PubMed  CAS  Google Scholar 

  • Christe W, Krämer G, Vigonius U, Pohlmann H, Steinhoff BJ, Brodie MJ, Moore A (1997) A double-blind controlled clinical trial: oxcarbazepine versus sodium valproate in adults with newly diagnosed epilepsy. Epilepsy Res 26:451–460

    Article  PubMed  CAS  Google Scholar 

  • Ciba-Geigy Limited (1996). International product information. Ciba, Basel

    Google Scholar 

  • Dam M, Ekberg R, Loyning Y, Waltimo O, Jakoben K (1989) A double-blind study comparing oxcarbazepine and carbamazepine in patients with newly diagnosed, previously untreated epilepsy. Epilepsy Res 3:70–76

    Article  PubMed  CAS  Google Scholar 

  • Degen PH, Flesch G, Cardot JM, Czendlik C, Dieterle W (1994) The influence of food on the disposition of the antiepileptic oxcarbazepine and its major metabolites in healthy volunteers. Biopharm Drug Dispos 15:519–526

    Article  PubMed  CAS  Google Scholar 

  • Fisher RS, Eskola J, et al. (1996) Open-label, pilot study of oxcarbazepine for inpatients under evaluation for epilepsy surgery. Drug Dev Res 38:43–49

    Article  CAS  Google Scholar 

  • Friis ML, Kristensen O, Boas J et al. (1993) Therapeutic experiences with 947 epileptic out-patients in oxcarbazepine treatment. Acta Neurol Scand 87:224–227

    Article  PubMed  CAS  Google Scholar 

  • Guerreiro MM, Vigonius U, Pohlmann H, de Manreza MLG, Fejerman N, Antonick SA, Moore A (1997) A double-blind controlled clinical trial of oxcarbazepine versus phenytoin in children and adolescents with epilepsy. Epilepsy Res 27:205–213

    Article  PubMed  CAS  Google Scholar 

  • Houtkooper MA, Lammertsma A, Meyer JW et al. (1987) Oxcarbazepine (GP 47680) — a possible alternative to carbamazepine? Epilepsia 28:693–698

    Article  PubMed  CAS  Google Scholar 

  • Isojarvi JIT, Pakarinen AJ, Rautio A, Pelkonen O, Mykyla W (1994) Serum sex hormone levels after replacing carbamazepine with oxcarbazepine. Pharmokinet Disposit:461–464

    Google Scholar 

  • Jensen NO (1983) Oxcarbazepine in patients hypersensitive to carbamazepine. 16th Epilepsy International Congress, Hamburg

    Google Scholar 

  • Keranen T, Jolkkonen J, Jensen P, Menge GP, Anderson P (1992) Absence of interaction between oxcarbazepine and erythromycin. Acta Neurol Scand 86:120–123

    Article  PubMed  CAS  Google Scholar 

  • Keränen T, Jolkkonen J, Klosterskov-Jensen P, Menge GP (1992) Oxcarbazepine does not interact with Cimetidine in healthy volunteers. Acta Neurol Scand 85:239–242

    Article  PubMed  Google Scholar 

  • Klosterskov Jensen P, Saano V, Saano V, Haring P, Svenstrup B, Menge GP (1992) Possible interaction between oxcarbazepine and an oral contraceptive. Epilepsia 33:1149–1152

    Article  Google Scholar 

  • Krämer G, Tettenborn B, Flesch G (1991) Oxcarbazepine-verapamil drug interaction in healthy volunteers. Epilepsia 32 [Suppl 1]:70–71

    Google Scholar 

  • Krämer G, Tettenborn B, Klosterskov-Jensen P, Menge GP, Stoll KD (1992) Oxcarbazepine does not affect the anticoagulant activity of warfarin. Epilepsia 33:1145–1148

    Article  PubMed  Google Scholar 

  • McLean MJ, Schmutz M, Wamil AW, Olpe HR, Portet C, Feldmann KF (1994) Oxcarbazepine: mechanisms of action. Epilepsia 35 [Suppl 3]:S5–S9

    Article  PubMed  Google Scholar 

  • Mogensen PH, Jorgensen L, Boas J, Dam M, Vesterager A, Flesch G, Jensen PK (1992) Effects of dextropropoxyphene on the steady-state kinetics of oxcarbazepine and its metabolites. Acta Neurol Scand 85:14–17

    Article  PubMed  CAS  Google Scholar 

  • Nielsen OA, Johannessen AC, Bardrum B (1988) Oxcarbazepine-induced hyponatremia, a cross-sectional study. Epilepsy Res 2:269–271

    Article  PubMed  CAS  Google Scholar 

  • Rouan MC, Lecaillon JB, Godbillon J et al. (1994) The effect of renal impairment on the pharmacokinetics of oxcarbazepine and its metabolites. Eur J Clin Pharmacol 47:161–167

    Article  PubMed  CAS  Google Scholar 

  • Schachter SC, Vazquez B et al. (1999) Oxcarbazepine: double-blind, randomised place-bocontrol, monotherapy trial for partial seizures. Neurology (in press)

    Google Scholar 

  • Schmutz M, Brugger F, Gentsch C, McLean MJ, Olbe HR (1994) Oxcarbazepine: preclinical anticonvulsant profile and putative mechanisms of action. Epilepsia 35 [Suppl 5]:S47–S50

    Google Scholar 

  • Sonnen AEH (1990) Oxcarbazepine and oral contraceptives. Acta Neurol Scand 82 [Suppl 133]:37

    Google Scholar 

  • Stefani A, Pisani A, DeMurtas M, Mercuri NB, Marciana MG, Calabresi P (1995) Action of GP 47779, the active metabolite of oxcarbazepine, on the corticostriatal system. II. Modulation of high-voltage-activated calcium currents. Epilepsia 36:997–1002

    Article  PubMed  CAS  Google Scholar 

  • Van Amelsvoort T, Bakshi R, Devauz CB, Schwabe S (1994) Hyponatremia associated with carbamazepine and oxcarbazepine therapy: a review. Epilepsia 35:181–188

    Article  PubMed  Google Scholar 

  • van Heiningen PN, Eve MD, Oosterhuis B et al. (1991) The influence of age on the pharmacokinetics of the antiepileptic agent oxcarbazepine. Clin Pharmacol Ther 50:410–419

    Article  PubMed  Google Scholar 

  • Van Parys JAP, Meinardi H (1994) Survey of 260 epileptic patients treated with oxcarbazepine (Trileptal) on a named-patient basis. Epilepsy Res 19:79–85

    Article  PubMed  Google Scholar 

  • Wamil AW, Portet CH, Jensen PK et al. (1991) Oxcarbazepine and its monohydroxy metabolite limit action potential firing by mouse central neurons in cell culture. Epilepsia 32 [Suppl 3]:65–66

    Google Scholar 

  • Wamil AW, Schmutz M, Portet C, Feldmann KF, McLean MJ (1994) Effects of oxcarbazepine and 10-hydroxycarbamazepine on action potential firing and generalized seizures. Eur J Pharmacol 271:301–308

    Article  PubMed  CAS  Google Scholar 

Download references

Authors
  1. S. C. Schachter
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Departments of Medicine, Royal Brisbane Hospital, University of Queensland, Clinical Sciences Building, Herston, Qld., 4029, Australia

    Mervyn J. Eadie AO, MD, PhD

  2. Australian Centre for Clinical Neuropharmacology, St. Vincent’s Hospital, Fitzroy, Victoria, 3065, Australia

    Frank J. E. Vajda M.D.

Rights and permissions

Reprints and permissions

Copyright information

© 1999 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Schachter, S.C. (1999). Oxcarbazepine. In: Eadie, M.J., Vajda, F.J.E. (eds) Antiepileptic Drugs. Handbook of Experimental Pharmacology, vol 138. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-60072-2_11

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-60072-2_11

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-64244-9

  • Online ISBN: 978-3-642-60072-2

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation